Limited Competition: Frequent Hemodialysis Network (U01)

The summary for the Limited Competition: Frequent Hemodialysis Network (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Frequent Hemodialysis Network (U01): Purpose: The primary objective of this initiative is a limited competition to continue recruitment and follow-up of two clinical trials of frequent hemodialysis. The Frequent Hemodialysis Network (FHN) is testing two different approaches to increasing dialysis at Clinical Centers in the U.S. and Canada. The FHN Daily Trial is a randomized controlled trial that randomizes 250 subjects to either conventional hemodialysis delivered for at least 2.5 hours, 3 days per week, or to more frequent hemodialysis delivered for 1.5 2.75 hours, 6 days per week. Subjects will be followed for 12 months. The FHN Nocturnal Trial randomizes 250 subjects to home conventional hemodialysis delivered three days per week or to nocturnal home hemodialysis given six times per week that provides a standardized Kt/V equal to or greater than 4 and treatment equal to or longer than 6.0 hours. Due to the necessity of training for home dialysis, subjects are followed for 14 months. Two outcomes are being assessed in both trials. The first is a composite measure of change in left ventricular mass or death. The second is a composite of change in the physical health composite of the SF36 or death Funds Available and Anticipated Number of Awards. The NIDDK intends to commit approximately $3.2 million in FY 2008 to make 4 awards. It is expected that an additional $0.5 million will be awarded in FY 2009. Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed two years. Total costs are limited to $800,000 dollars in the first year. Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the cooperative agreement (U01) grant mechanism Eligible organizations include. As this FOA is a limited competition opportunity that involves a continuation of the cooperative agreements supporting the FHN clinical trials, only the current U01 FHN awardees are eligible to submit applications. Eligible principal investigators include individuals from the existing FHN CCs with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Federal Grant Title: Limited Competition: Frequent Hemodialysis Network (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DK-07-503
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.849
CFDA Descriptions: Kidney Diseases, Urology and Hematology Research
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 31, 2007
Posted Date: Aug 10, 2007
Creation Date: Aug 10, 2007
Archive Date: Nov 30, 2007
Total Program Funding: $3,200,000
Maximum Federal Grant Award: $800,000
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. As this FOA is a limited competition opportunity that involves a continuation of the cooperative agreements supporting the FHN clinical trials, only the current U01 FHN awardees are eligible to submit applications. Individuals from the existing FHN CCs with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Investigations on Primary Immunodeficiency Diseases (R01)
Grants for Basic Research in Glomerular Diseases (R01)
Advances in Polycystic Kidney Disease (R01)
Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
Calcium Oxalate Stone Diseases (R01)
Research Grants for Clinical Studies of Kidney Diseases
Chronic Prostatitis Collaborative Research Network (Cpcrn)
Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com